Vyaderm Pharmaceuticals: The EVA Decision - Case Solution
Robert L. Simons and Indra A. Reinbergs | Harvard Business Review ( 101019-PDF-ENG ) | October 04, 2000 (Revision: 2023-09-09)
Abstract:
The Vyaderm Pharmaceuticals: The EVA Decision case study allows students to calculate the EVA (Economic Value Added) for a company as well as the bonus for the head of the Dermatology division.
Case Questions Answered
- Calculate the EVA (Economic Value Added) for Vyaderm Pharmaceuticals Dermatology Division.
- Calculate the bonus for the head of the Dermatology division.
This case solution includes an Excel file with calculations that will be available after purchase.
This case solution includes an Excel file with calculations.
1. Calculate the EVA (Economic Value Added) for Vyaderm Pharmaceuticals
Dermatology Division.
The EVA calculation for the Dermatology Division of Vyaderm Pharmaceuticals is illustrated below:
Case Solution
$24.90
- Full written analysis
- All case questions answered
- Excel spreadsheet included
- Instant delivery to your email
Get Instant Access
Secure No account neededInstant access
By clicking “Get Instant Access”, you agree to our Terms of Use, Arbitration and Class Action Waiver Agreement and Privacy Policy